Compare Esperance Pharmaceuticals vs Stemina Biomarker Discovery
Customers evaluate the quality of Esperance Pharmaceuticals's products using the following success metrics.
Overview
Esperance Pharmaceuticals is 19 yrs old and is based in United States.
Esperance Pharmaceuticals develops targeted anticancer drugs that selectively kill cancer cells without harming normal cells.
Stemina Biomarker Discovery is 18 yrs old and is based in United States.
Stemina Biomarker Discovery is a developer of molecular biomarkers designed to perform diagnosis and treat neurological disorders, including autism spectrum disorders. It offers the discovery, development, and commercialization of molecular biomarkers for drug safety and human health. It provides compound screening and diagnostic development for the pharmaceutical and biotechnology industries. The company was founded in 2006 and is based in Madison, Wisconsin.
Demo Video
Leadership
Hector Alila (Founder, Chief Executive Officer, President)
Gabriela Cezar (Founder)
Funding
Investors
Louisiana Funds, Research Corporation Technologies
Arenberg Holdings, Paycheck Protection Program
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Esperance Pharmaceuticals has not claimed their profile.
Work for Esperance Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Esperance Pharmaceuticals?
Claim your profile now.
Information not available because Stemina Biomarker Discovery has not claimed their profile.
Work for Stemina Biomarker Discovery? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Stemina Biomarker Discovery?
Claim your profile now.